GSK and Viome expand microbiome-based cancer therapeutics deal
GlaxoSmithKline (GSK) are to expand on an existing collaboration with Viome that looks into links between the gut microbiome and certain cancers.
France General Naveen Jain Rino Rappuoli Eligo Bioscience Metatranscriptomic Sequencing Technology Artificial Intelligence
Source: nutraingredients.com